Spots Global Cancer Trial Database for uterine papillary serous carcinoma
Every month we try and update this database with for uterine papillary serous carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of INCB123667 in Subjects With Advanced Solid Tumors | NCT05238922 | Solid Tumors | INCB0123667 | 18 Years - | Incyte Corporation | |
A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | NCT00231829 | Uterine Cancer | Celecoxib | 18 Years - | Montefiore Medical Center | |
Study of INCB123667 in Subjects With Advanced Solid Tumors | NCT05238922 | Solid Tumors | INCB0123667 | 18 Years - | Incyte Corporation | |
Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma | NCT00506779 | Uterine Cancer | Imatinib Mesyla... Paclitaxel | - | M.D. Anderson Cancer Center | |
Study of INCB123667 in Subjects With Advanced Solid Tumors | NCT05238922 | Solid Tumors | INCB0123667 | 18 Years - | Incyte Corporation | |
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma | NCT00231868 | Uterine Cancer | Carboplatin and... Carboplatin and... Carboplatin and... | 18 Years - | Montefiore Medical Center | |
A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers | NCT00231829 | Uterine Cancer | Celecoxib | 18 Years - | Montefiore Medical Center |